Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2
List of Figures 5
2 Company Snapshot 6
2.1 Key Information 6
2.2
Company Overview 6
3 Clinical Cell Culture Limited Pipeline Products 7
3.1 Clinical Cell Culture Limited Product Pipeline Analysis 7
3.1.1
Clinical Cell Culture Limited Pipeline Products By Equipment Type 7
3.1.2
Clinical Cell Culture Limited Pipeline Products By Development Stage 8
3.1.3 Clinical Cell Culture Limited Pipeline Products By Therapy Area 9
3.1.4 Clinical Cell Culture Limited Pipeline Products By Clinical Trials 9
3.1.5 Clinical Cell Culture Limited Pipeline Products By News Summary 10
3.2 Cell Delivery Device (CDD) 11
3.2.1 Product Status 11
3.2.2
Product Description 11
3.3 ReCell 12
3.3.1 Product Status 12
3.3.2
Product Description 12
3.3.3 Product Milestone 12
3.3.4 ReCellClinical
Trials 1 13
3.3.5 ReCellClinical Trials 2 14
3.3.6 ReCellClinical
Trials 3 14
3.3.7 ReCellClinical Trials 4 15
3.4 CellSpray 15
3.4.1 Product Status 15
3.4.2 Product Description 16
3.4.3 Product
Milestone 17
3.5 CellSpray XP 17
3.5.1 Product Status 17
3.5.2
Product Description 18
4 Recent Developments 19
4.1 Product News
19
4.1.1 Aug 07, 2008: Avita Signs Greek Distribution Deal 19
4.1.2
Jul 21, 2008: Chinese SFDA Approves Helicon Group' s ReCell Concept And Kit
19
4.1.3 Jul 03, 2008: Avita ReCell Product Approved In China 19
4.1.4
Dec 15, 2006: Recell Approved In Brazil And Turkey 20
4.1.5 Nov 27, 2006:
Update On US Regulatory Approval For Recell 20
4.1.6 Nov 14, 2006: Recell
Clinical Update 21
4.1.7 Nov 08, 2006: Cellspray Approved In Greece 21
4.1.8 Sep 28, 2006: Clinical Cell Culture Announces CSL Supply Agreement
21
4.1.9 Jun 27, 2006: Recell Approved In Canada 22
4.1.10 May 25,
2006: TGA Approves Recell 22
4.1.11 Apr 03, 2006: TGA Recommends Recell
For Approval 22
4.1.12 Jan 16, 2006: Regulatory Update On Recell FDA And
TGA 23
4.1.13 Oct 28, 2005: First Patient Treated With New CellSpray Burn
Treatment From Clinical Cell Culture 24
4.2 Product Approvals 24
4.2.1
Jul 21, 2008: Chinese SFDA Approves Helicon Group' s ReCell Concept And Kit
24
4.2.2 Jul 03, 2008: Avita ReCell Product Approved In China 24
4.2.3
Dec 15, 2006: Recell Approved In Brazil And Turkey 25
4.2.4 Nov 08, 2006:
Cellspray Approved In Greece 25
4.2.5 Jun 27, 2006: Recell Approved In
Canada 25
4.2.6 May 25, 2006: TGA Approves Recell 26
4.3 Clinical
Trials 26
4.3.1 Nov 14, 2006: Recell Clinical Update 26
5 Appendix
27
5.1 Methodology 27
5.1.1 Coverage 27
5.1.2 Secondary Research
28
5.1.3 Primary Research 28
5.1.4 Expert Panel Validation 29
5.2
Contact Us 29
5.3 About Global Markets Direct 29
5.4 Disclaimer 29
1.1 List of Tables
Table 1: Clinical Cell Culture
Limited,Key Facts 6
Table 2: Clinical Cell Culture Limited Pipeline
Products by Equipment Type 7
Table 3: Clinical Cell Culture Limited
Pipeline Products By Development Stage 8
Table 4: Clinical Cell
Culture Limited Pipeline Products By Therapy Area 9
Table 5: Clinical
Cell Culture Limited Pipeline Products By Clinical Trials 9
Table 6:
Clinical Cell Culture Limited Pipeline Products By News Summaries 10
Table
7: Cell Delivery Device (CDD), Product Status 11
Table 8: Cell
Delivery Device (CDD), Product Description 11
Table 9: ReCell,
Product Status 12
Table 10: ReCell, Product Description 12
Table
11: ReCellClinical Trials 1 13
Table 12: ReCellClinical Trials 2
14
Table 13: ReCellClinical Trials 3 14
Table 14:
ReCellClinical Trials 4 15
Table 15: CellSpray, Product Status 15
Table 16: CellSpray, Product Description 16
Table 17: CellSpray
XP, Product Status 17
Table 18: CellSpray XP, Product Description
18
1.2 List of Figures
Figure 1: Clinical Cell
Culture Limited Pipeline Products By Development Stage 8
Figure 2:
Clinical Cell Culture Limited Pipeline Products By News Summary 10
Figure
3: Global Markets Direct Methodology 27
| 
View Cart
